Purchase Order HHSD2002016M91980P
- Not listed
- This is a firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a for-profit manufacturer of genetic sequencing instruments and reagents. The contract is for the provision of an Illumina MiSeq genomic sequencing system, with a ceiling value of $135,435.37 and a performance period ending on November 30, 2015. The order does not have a set-aside designation. Illumina has previously received prime federal contract awards from agencies...
- This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract is for the provision of Genomic Sequencing Kits with a ceiling value of $170,641.14 and a performance period ending on August 28, 2024. The contract does not utilize a set-aside designation. Illumina is the prime contractor and has been awarded multiple federal contracts...
- This is a firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents. The contract is for MiSeq and MiniSeq sequencing systems and reagents, with a ceiling value of $132,300.66 and a period of performance through August 31, 2016. This contract does not have a set-aside designation. Illumina has a history of providing sequencing instruments, reagents, and related services to federal...
- This is a federal purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The contract has a ceiling value of $113,260.75 and is for the delivery of laboratory equipment. The contract is for a firm fixed price and has an ultimate completion date of August 31, 2017. There is no set-aside designation mentioned. Illumina has previously been awarded prime contracts and...
- This is a firm fixed price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc. for the supply of lab supplies. The contract has a ceiling value of $97,152 and runs through February 28, 2017. The contract is not set aside for any special business designation. Illumina is a manufacturer and provider of sequencing and array-based solutions for genetic and genomic analysis. Through past federal contract awards, Illumina has provided a range of...
- This is a firm fixed price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract is for the provision of a MiSeq system, a DNA sequencing instrument, at a ceiling value of $95,931.00. The contract does not have a set-aside designation. Illumina has previously been awarded other prime federal contracts and sub-grants to provide sequencing...
- This is a firm fixed price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genetic sequencing systems and related products. The contract is for the maintenance, repair, and support of Illumina's NovaSeq 6000 and MiSeq sequencing instruments over a 2-year period, with a ceiling value of $139,336.76. This contract does not have a set-aside designation. Illumina has previously received prime federal contracts and...
- This is a firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc. for the provision of MiSeq sequencer and MiniSeq system equipment. The total ceiling value of the contract is $144,985.50, with a period of performance ending on May 9, 2016. Illumina is a manufacturer of genetic and genomic analysis instruments and reagents, and has previously provided sequencing systems and related products to support research and diagnostics at various...
- This is a firm fixed price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc. for a MiSeq System, sequencing instrument and associated services. The contract has a ceiling value of $97,020.00 and was awarded on April 13, 2022, with a completion date of July 1, 2022. This contract was not set aside for a specific business type. Illumina is a for-profit manufacturer of genomic sequencing and analysis products, and has experience providing...
- This is a $94,050.00 firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of sequencing and analysis instruments and reagents. The award is for an Illumina MiSeq sequencing system and does not have a set-aside designation. Illumina has a history of providing sequencing equipment and services to support research and diagnostics across various federal agencies, including the National Institutes of Health, Department of...
This is a firm fixed price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The contract has a ceiling value of $77,888.22 and will support the delivery of HI-/MI-SEQ KITS with a period of performance ending on September 30, 2016. The contract does not have a set-aside designation. Illumina has previously received prime federal contract awards from agencies such as the National Institutes of Health, USDA, and Department of Veterans Affairs to provide a range of sequencing systems, reagents, and related services. The CDC contract appears to be part of the agency's genomic sequencing and analysis activities, potentially supporting research or diagnostic applications.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| 1 | Other Administrative Action | $0 | 10/21/16 | |
| Not listed | Not listed | $77.9k | 8/25/16 |